US turns back on global coronavirus vaccine effort: Live news | News
Hello and welcome to Al Jazeera’s continuing coverage of the coronavirus pandemic. I’m Kate Mayberry in Kuala Lumpur, keeping you updated for the next few hours.
- The United States is turning its back on the COVID-19 Vaccines Global Access Facility (COVAX), a global effort to develop and distribute a coronavirus vaccine that is being led by the World Health Organization (WHO).
- The latest data from Johns Hopkins University shows more than 25.6 million people around the world have been diagnosed with the coronavirus, and 853,290 have died. Nearly 17 million people have recovered.
Here are all the latest updates:
Wednesday, September 2
00:00 GMT – US turns back on global vaccine effort
The United States has said it will not join the World Health Organization-led global push for a coronavirus vaccine.
More than 150 countries have established the COVID-19 Vaccines Global Access Facility, known as COVAX, but the US says it will not join because it does not want to be “constrained” by multilateral organisations like the WHO. It pulled out of the WHO in early July.
“The United States will continue to engage our international partners to ensure we defeat this virus, but we will not be constrained by multilateral organisations influenced by the corrupt World Health Organization and China,” said White House spokesman Judd Deere.
Read more on this story here.
23:30 GMT (Tuesday) – UN to hold summit on post-pandemic global governance
Niger, the current president of the United Nations Security Council, is organising a September 24 videoconference between heads of state to discuss the future of global governance following the coronavirus pandemic.
The summit will debate “post-COVID-19 global governance in relation to the maintenance of international peace and security,” Niger’s UN Ambassador Abdou Abarry told journalists.
The session will take place during the annual UN General Assembly gathering of world leaders, which will take place this year mainly by videoconference because of the pandemic.
“This will be an opportunity for our leaders to have political discussions on the need to adapt the current international system embodied by the United Nations and the Security Council in order to effectively face traditional threats to security such as conflicts, but also new threats such as organised crime and pandemics,” Abarry said.
23:00 GMT (Tuesday) – Recovered COVID-19 patients retain antibodies for months
A new study from Iceland has found antibody levels against the novel coronavirus rose and then held steady for up to four months in more than 90 percent of recovered COVID-19 patients.
Kari Stefansson, chief executive of deCODE Genetics, which conducted the study, says the findings could have implications for reinfection risks and vaccine durability.
Researchers measured antibody levels in more than 30,000 Icelanders.
Based on the results, they estimate that about one cent of the population had been infected. Of that group, 56 percent had received a confirmed diagnosis after a polymerase chain reaction (PCR) laboratory test. A further 14 percent had not been formally diagnosed, but had been quarantined after exposure to the virus. For the remaining 30 percent, the antibody tests led to the discovery of prior infection.
Among the 1,215 people with an infection confirmed by PCR, 91 percent had antibody levels that rose during the first two months after diagnosis and then plateaued, researchers reported.
The results were published in The New England Journal of Medicine on Tuesday.
Read all the updates from yesterday (September 1) here.
Al Jazeera and news agencies